Business

Announcement on Amisulpride Orodispersible Tablets Passing the National Medical Insurance Negotiation and Being Successfully Included in the National Medical Insurance Catalog

Announcement on Amisulpride Orodispersible Tablets Passing the National Medical Insurance Negotiation and Being Successfully Included in the National Medical Insurance Catalog

articleShanghai Pharmaceuticals Holding Co. Ltd. Class ADecember 8, 20255/news/announcement-on-amisulpride-orodispersible-tablets-passing-the-national-medical-insurance-negotiation-and-being-successfully-included-in-the-national-medical-insurance-catalog
Announcement on Amisulpride Orodispersible Tablets Passing the National Medical Insurance Negotiation and Being Successfully Included in the National Medical Insurance Catalog

About this update from Shanghai Pharmaceuticals Holding Co. Ltd. Class A

Announcement on Amisulpride Orodispersible Tablets Passing the National Medical Insurance Negotiation and Being Successfully Included in the National Medical Insurance Catalog The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Shanghai Pharmaceuticals Holding Co. Ltd. Class A